Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leanne Purins

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|December 9, 2008
Sequence-structure relationships in polysaccharide co-polymerase (PCP) proteinsRenato Morona, Leanne Purins, Ante Tocilj, et al.
Microbiology (Reading, England)|April 1, 2008
Coiled-coil regions play a role in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2Leanne Purins, Luisa Van Den Bosch, Vanessa Richardson, et al.
Microbiology (Reading, England)|October 6, 2000
The Vibrio cholerae O1 chromosomal integronChristopher A Clark, Leanne Purins, Pranom Kaewrakon, et al.
World Journal of Gastroenterology|February 28, 2014
Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelledKim Y C Fung, Edouard Nice, Ilka Priebe, et al.
Nature Structural & Molecular Biology|January 22, 2008
Bacterial polysaccharide co-polymerases share a common framework for control of polymer lengthAnte Tocilj, Christine Munger, Ariane Proteau, et al.
Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancerKim Y C Fung, Ilka Priebe, Leanne Purins, et al.
Blood Advances|January 4, 2018
<i>ASXL1</i> and <i>BIM</i> germ line variants predict response and identify CML patients with the greatest risk of imatinib failureJustine E Marum, David T Yeung, Leanne Purins, et al.
Plos One|March 21, 2015
Blood-based protein biomarker panel for the detection of colorectal cancerKim Y C Fung, Bruce Tabor, Michael J Buckley, et al.
Blood|May 27, 2014
Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 declineSusan Branford, David T Yeung, Wendy T Parker, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|December 9, 2008
Sequence-structure relationships in polysaccharide co-polymerase (PCP) proteinsRenato Morona, Leanne Purins, Ante Tocilj, et al.
Microbiology (Reading, England)|April 1, 2008
Coiled-coil regions play a role in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2Leanne Purins, Luisa Van Den Bosch, Vanessa Richardson, et al.
Microbiology (Reading, England)|October 6, 2000
The Vibrio cholerae O1 chromosomal integronChristopher A Clark, Leanne Purins, Pranom Kaewrakon, et al.
World Journal of Gastroenterology|February 28, 2014
Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelledKim Y C Fung, Edouard Nice, Ilka Priebe, et al.
Nature Structural & Molecular Biology|January 22, 2008
Bacterial polysaccharide co-polymerases share a common framework for control of polymer lengthAnte Tocilj, Christine Munger, Ariane Proteau, et al.
Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancerKim Y C Fung, Ilka Priebe, Leanne Purins, et al.
Blood Advances|January 4, 2018
<i>ASXL1</i> and <i>BIM</i> germ line variants predict response and identify CML patients with the greatest risk of imatinib failureJustine E Marum, David T Yeung, Leanne Purins, et al.
Plos One|March 21, 2015
Blood-based protein biomarker panel for the detection of colorectal cancerKim Y C Fung, Bruce Tabor, Michael J Buckley, et al.
Blood|May 27, 2014
Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 declineSusan Branford, David T Yeung, Wendy T Parker, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Pageof 1